Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Guangdong Yuewei Edible Fungi Technology Co. Ltd. has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This single matter is assigned to 1 distinct examiner and 1 distinct art unit, indicating a very narrow and specific focus for the company's current patent prosecution. This concentration allows for a streamlined approach to managing the portfolio, as there is only one set of examiner guidelines to consider.
HOFFMAN, SUSAN COE is the busiest examiner, with 1 pending office action. This examiner is responsible for the company's total current workload of 1 pending office action. For the practitioner, this means that the entire success of the current pending portfolio rests with HOFFMAN, SUSAN COE. The presence of 1 examiner in 1 art unit for the pending office action ensures that there are no competing priorities or differing examiner styles to navigate at this time.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HOFFMAN, SUSAN COE | 1 | 54.2% | +25.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18692974 | Anti-Oxidant Repair Ganoderma Lucidum Extract and Preparation Method Therefor | HOFFMAN, SUSAN COE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18692974 | Anti-Oxidant Repair Ganoderma Lucidum Extract and Preparation Method Therefor | HOFFMAN, SUSAN COE | — |
| Art Unit | Apps |
|---|---|
| 1655 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18692974 | Anti-Oxidant Repair Ganoderma Lucidum Extract and Preparation Method Therefor | HOFFMAN, SUSAN COE | 1655 | §103§112 | Non-Final OA | — | Pending | Aug 12, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialGuangdong Yuewei Edible Fungi Technology Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Susan Coe Hoffman has the most, with 1 of Guangdong Yuewei Edible Fungi Technology Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
